CYTOMED THERAPEUTICS LIMITED
GDTC·Y1R80M106·US·Common Stock·Healthcare - Biotechnology-Activist
GDTC (CYTOMED THERAPEUTICS LIMITED) is held by 2 institutional investors as of Q2 2026. Largest holders: UBS Group AG ($4,976), OSAIC HOLDINGS, INC. ($21). Net institutional sentiment: Bearish.
2
Holders
$4,997
Total Value
0% (2)
Consensus
0 buying - 2 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Jul 24, 2026 · Activists Oct 13, 2026 · Congress none
ActivistCCChoo Chee Kong24.9%Oct 13, 2026
ActivistCCChoo Chee Kong24.3%Jul 24, 2026
InsiderCKChoo Chee KongBuy $150KJul 20, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer